Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000290827 | SCV000332230 | uncertain significance | not provided | 2015-06-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001087362 | SCV000761074 | likely benign | Familial hypocalciuric hypercalcemia; Autosomal dominant hypocalcemia 1 | 2024-09-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004021076 | SCV001179653 | likely benign | Nephrolithiasis/nephrocalcinosis | 2024-01-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV000290827 | SCV005079011 | uncertain significance | not provided | 2023-06-28 | criteria provided, single submitter | clinical testing | In silico analysis supports that this variant does not alter splicing; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 36315513) |